It is widely accepted that there are two principal forms of cell death; namely, necrosis and apoptosis. According to the classical view, necrosis is the major mechanism of cardiomyocyte death in cardiac diseases. However, in the past few years observations have been made showing that cardiomyocyte apoptosis occurs in diverse conditions and that apoptosis may be a contributing cause of the loss and functional abnormalities of cardiomyocytes with important pathophysiological consequences. In this regard, although a number of formal proofs are pending, it is conceivable that cardiomyocyte apoptosis may be an important variable in the clinical evolution of hypertensive cardiomyopathy. This review summarizes recent evidence demonstrating that cardiomyocyte apoptosis is abnormally stimulated in the heart of animals and humans with arterial hypertension. In addition, the potential mechanisms of cardiomyocyte apoptosis in hypertension and its detrimental impact on cardiac function will be addressed. Finally, the perspectives of strategies aimed to detect and modulate apoptosis of cardiomyocytes in hypertensive cardiomyopathy will be considered.
. Overview of apoptosis

.1. The apoptotic process
Cell death occurs by necrosis or apoptosis [1] . These Apoptosis is a form of cell death that results in loss of two processes have distinct histologic and biochemical cell volume, plasma membrane blebbing, nuclear concharacteristics. In necrosis, the stimulus of death (e.g., densation, chromatin aggregation, and endonucleocytic ischemia) is itself often the direct cause of demise of the degradation of DNA [2, 3] . Apoptotic death occurs as a cell. In apoptosis, by contrast, the stimulus of death consequence of the activation of cell surface death reactivates a cascade of events that orchestrate the destrucceptors (e.g., tumor necrosis factor receptor superfamily of tion of the cell. Unlike necrosis, which is a pathologic proteins, TNFR, and Fas receptor) by extracellular ligands process, apoptosis is part of normal development (physio-(e.g., TNF and Fas Ligand, FasL) [4, 5] and / or the activalogic apoptosis); however, it also occurs in a variety of tion of mitochondrial-related pro-apoptotic mechanisms in diseases (pathologic apoptosis).
response to unfavorable changes in the intracellular environment [6, 7] . After ligand binding, death receptors interact with a TRADD, RIP, and Daxx, which act downstream of the 1 .2. Apoptosis in the cardiomyocyte activated death receptor to activate a cascade of cell signaling pathways (e.g., MAP kinase, NF-kB and Akt)
A number of different experimental models have been that regulate gene expression and the phosphorylation used to demonstrate the ability of the cardiomyocyte to status of proteins (e.g., Bcl-2 proteins and IAP proteins) activate and die by apoptosis in response to a range of [8, 9] , which, in turn, modulate the activity of different stresses, including work overload, hypoxia, neuro-humoral families of proteases (e.g., caspases, cathepsins and caloverstimulation, free radical stress, viral infection and pains) involved in the execution of the final steps of the toxic insults [24] . Although no single model perfectly apoptotic process [10] [11] [12] . Whereas the stimulation of represents the conditions in the adult human heart or the some MAP kinase pathways is associated with pro-apobiochemical properties of the adult human ventricular ptotic effects (e.g., JNK and p38), activation of other MAP cardiomyocyte, these studies have shown that these carkinase pathways is accompanied by anti-apoptotic effects diomyocytes possess the necessary machinery for apop-(e.g., ERK) [13] . On the other hand, stimulation of NF-kB tosis. and Akt pathways mediates anti-apoptotic effects [14, 15] .
In fact, Fas receptor and TNFR-1 are expressed in The balance between negative and positive regulation by cardiomyocytes and are induced by various types of these signaling pathways is thought to be essential for the oxidative and toxic stresses [25, 26] . Complex alterations in determination of cell fate.
the levels of Bcl-2 proteins occur in various forms of In addition to their established role in energy promyocardial stress, including mechanical deformation secduction, mitochondria are actively involved in the regulaondary to hemodynamic loading [27] , hypoxia-reoxygenation of apoptosis. In essence, changes in the internal tion [28] , and nitric oxide (NO) exposure [29] . These environment of the cell may modify the permeability of the studies show that the levels of both pro-apoptotic and outer mitochondrial membrane through changes in memanti-apoptotic Bcl-2 proteins can increase in response to brane potential, thus facilitating the release into the cytosol myocardial stress and are associated with changes in of a number of highly lethal mitochondrial substances that mitochondrial membrane potential [30] . The release of can initiate apoptosis. One of these is the small electron cytochrome c has been shown in cardiomyocytes in transporter cytochrome c that forms an apoptosis-promotresponse to serum and glucose deprivation, redox stress ing complex, the apoptosome, with procaspase-9 and its and constitutive activation of selves, but removal of inhibitory influences (e.g., IAPs) is accompanied by cardiomyocyte apoptosis due to activation also necessary. In this setting, mitochondria can also of the mitochondrial death pathway [33] . Interestingly, release a specific inhibitor of IAPs: second mitochondriaactivated JNKs are detected in the mitochondria of adult derived activator of caspases (Smac), also known as direct myocytes subjected to hypoxia, and are associated with the IAP-binding protein with low pI (Diablo) [17] . apoptotic response [34] , thus suggesting that some MAP In recent years, major progress has been made in kinases may directly activate the mitochondrial apoptotic understanding that whether apoptosis is initiated through machinery in these cells. On the other hand, activation of the death receptor pathway or through the mitochondrial various combinations of MAP kinases occurs in response pathway, interactions between the two pathways may to ischemia-reperfusion, b-adrenergic stimulation, NO and occur [18] . For example, the pro-apoptotic protein Bid is anthracycline exposure and has been implicated in survival cleaved by caspase-8 in response to FAS and TNF receptor signaling in cardiomyocytes [35] [36] [37] . Finally, the ability of activation [19, 20] . Following cleavage, the C-terminal some hypertrophic agents (e.g., insulin-like growth factorfragment of Bid translocates and binds to the mitochon-1, IGF-1, and cardiotrophin-1) to promote cardiomyocyte dria, leading to the release of cytochrome c and activation survival correlates with activation of the Akt pathway of downstream caspases. Another example is that of the [38, 39] . apoptosis signal-regulating kinase 1 (ASK1), which is a It is clear, therefore, that, although there is the potential member of the MAP kinase family, which activates JNK to induce cardiomyocyte cell death, stimulation of either and p38 activates and executes apoptosis mainly by the TNFR or the FAS receptor does not necessarily do so. mitochondria-dependent caspase activation, probably inBoth receptors have the potential to activate NFkB, which volving the phosphorylation and inactivation of the antiis cytoprotective in many systems, but activation of apoptotic protein Bcl-2 that prevents the release of cytocaspases might be expected to occur within the time chrome c [21] . Thus, Bcl-2 family proteins are considered required for NFkB-dependent transcription / translation to as mediators linking the death receptor signals to the take effect. Thus, although NFkB may mediate carmitochondria-dependent death signals [22, 23] .
diomyocyte cytoprotection, this is likely to be a longer-term effect. Components of the death receptor pathway, diomyocytes prevent downstream activation of caspase-3, including caspase-8, are expressed in cardiomyocytes, but and lose DNAases to preserve nuclear integrity and defer there are also significant levels of antagonist proteins such widespread loss of cytoplasmic proteins [47] [48] [49] . as cFLIPs [40] . Since receptor-mediated cell death is highly dependent on the protein-protein interaction, the level of expression of these different proteins significantly 2 . Cardiomyocyte apoptosis in hypertensive influences the outcome for the cell. Under normal concardiomyopathy ditions, high expression of inhibitory proteins (such as cFLIPs) in the heart may prevent apoptosis, but in response Although apoptosis of cardiomyocytes has been detected to cellular stresses, the expression of such proteins may be in different cardiac disease states (Table 1 ) and its altered. For example, cFLIP is downregulated in terminally occurrence has been reported to be of pathophysiological failing human hearts [41] and in apoptotic grafted significance in these conditions (reviewed in Refs. [75-myocytes [40] , which may be expected to increase the 79]), only recently has a critical role for cardiomyocyte sensitivity to death receptor-induced apoptosis. Such a apoptosis been suggested in hypertensive cardiomyopathy mechanism may account for the apparent anomaly in that (defined here as a greater than normal left ventricular mass overexpression of FasL in transgenic mice is insufficient to in the absence of a cause other than arterial hypertension). induce apoptosis [42] , whereas ischemia / reperfusion-induced apoptosis is decreased in animals with a defective 2 .1. Experimental findings Fas receptor [43] . Overall, it seems probable that the death receptors do play a significant role in cardiomyocyte Increased apoptosis has been demonstrated in the hyapoptosis, but the precise role depends on the physiologipertrophied left ventricle of spontaneously hypertensive cal setting. Therefore, it has been proposed that the death rats (SHR) [80] [81] [82] [83] , rats with renal hypertension [84] , rats receptor signaling to apoptosis may prove particularly with angiotensin II-induced hypertension [85] and Dahl significant in later phases of cardiac diseases in which salt-sensitive hypertensive rats [86] compared with their death receptors and their ligands have been upregulated normotensive control animals. In addition, an increased and protective pathways have become attenuated [44] .
occurrence of cardiomyocyte apoptosis has been found in Evidence is accumulating that cells exposed to death the heart from failing SHR as compared to non-failing signals actively try to protect themselves through a number SHR [81] . The SHR is a genetic model of hypertension in of mechanisms. When successful, such mechanisms may which early hypertrophic adaptation to hypertension and keep the cell alive, a factor especially important in subsequent transition to severe heart failure and premature terminally differentiated cells like the cardiomyocytes.
death occur [87, 88] . The transition from compensated Some of the known mechanisms include release of endoghypertrophy to heart failure in SHR is accompanied by enous anti-apoptotic factors to block the actions of cytonumerous structural and functional changes, including a chrome c [45] , or a change in PARP and / or ATP levels reduction in the relative cardiomyocyte mass [89] . Thus, [46] to modulate the apoptotic pathway. In this setting, it apoptosis might be a mechanism involved in carhas been reported that, although there is continuous diomyocyte loss that accompanies the transition from evidence of caspase-8 activation and mitochondrial cytostable compensation to heart failure in this model. chrome c release in cardiomyopathic hearts, car-2 .2. Clinical findings
Cardiomyocyte apoptosis has been shown to be abnorClinical conditions in which increased apoptosis of cardiomyocytes has mally stimulated in the hypertrophied heart of patients with been described in humans essential hypertension, no angiographic evidence of cor-
onary artery disease and normal cardiac function [90, 91] In the absence of heart failure ( Fig. 1 ). In addition, recent findings from our laboratory Postnatal morphogenesis [50, 51] indicate that cardiomyocyte apoptosis is increased in hearts Acute myocardial infarction [52] [53] [54] [55] [56] from hypertensive patients with chronic heart failure Cardiac allograft rejection [57] [58] [59] compared with hearts from hypertensive patients with left
In the presence of heart failure ventricular hypertrophy and normal cardiac function [92] .
Ischemic cardiomyopathy [47, [60] [61] [62] [63] [64] [65] In fact, increased cardiomyocyte apoptotic index and
Idiopathic dilated cardiomyopathy [47, [60] [61] [62] [63] [64] [65] [66] [67] [68] active caspase-3 expression was found in hypertensive Acromegalic cardiomyopathy [69] failing hearts compared with hypertensive hypertrophic Diabetes / hypertension [70] Arrhythmogenic right ventricular dysplasia [68, 71, 72] hearts and normotensive hearts in this study ( Fig. 1 ). On Myocarditis [73] the other hand, moderate cardiomyocyte loss has been
Hypertrophic cardiomyopathy [68, 74] demonstrated in long-term systemic hypertension with no clinical evidence of heart failure [93, 94] . Interestingly, we hypertensive Sprague-Dawley rats and blockade of the have found a severe loss of cardiomyocytes in failing type 1 angiotensin II (AT ) receptor with losartan prevents 1 hearts from hypertensive patients compared with hearts this effect despite the persistence of increased blood from hypertensive patients with left ventricular hyperpressure [85] . Second, an association has been found trophy and normal cardiac function [92] . Thus, it seems between enhanced cardiomyocyte apoptosis and exaggerthat apoptosis and cardiomyocyte loss precedes the impairated angiotensin converting enzyme (ACE) activity in the ment in ventricular function and its exacerbation accomleft ventricle of SHR [80] . Finally, chronic treatment with panies the development of heart failure in hypertensive losartan at doses that do not normalize blood pressure is patients.
associated with a reduction of cardiomyocyte apoptosis in both SHR [94] and hypertensive patients [90] .
In vitro studies have shown that angiotensin II binding 3 . Pathogenetic mechanisms of AT receptors triggers apoptosis by a mechanism 1 involving stimulation of p38 MAP kinase activity, activaCardiomyocyte apoptosis has been proposed to occur as tion of p53 protein and subsequent decrease of the Bcl-2-a result of an imbalance between the factors that induce or to-Bax protein ratio, activation of caspase-3, stimulation of block apoptosis [95] . Thus, arterial hypertension may calcium-dependent DNase I, and internucleosomal DNA represent a condition in which inducers of cardiomyocyte fragmentation [98, [104] [105] [106] [107] (Fig. 2) . Although angiotensin apoptosis predominate over suppressors of cardiomyocyte II has been shown to induce apoptosis in other carapoptosis [96] . which mimics an elevation of diastolic stress in vivo, panied by normalization of cardiac apoptosis in rats with resulted in an increase in cardiomyocyte apoptosis [98, 99] .
angiotensin II-induced hypertension that exhibit increased Interestingly, augmented superoxide formation and expresexpression of AT receptors in the heart [85] 2 sion of Fas receptor were observed in this condition. The In the heart, aldosterone promotes hypertrophy and addition of the NO-releasing drug C87-3754 prevented fibrosis. Recently, De Angelis et al. [110] have reported apoptosis and superoxide anion formation [98] . Therefore, that aldosterone induces ventricular cardiomyocyte apopthe induction of superoxide seems to be a relevant factor in tosis in vivo and in cultured cells. The effect of aldosterone overstretching-induced cardiomyocyte apoptosis. On the seems to be directed to the cardiomyocyte and is mediated other hand, mechanical stretch causes release of humoral by mineralocorticoid receptors, since it is abolished by factors from cardiomyocytes that may induce apoptosis in spironolactone in primary culture of these cells [110] . these cells [100] . Thus, it is possible that physical forces Interestingly, cardiomyocyte apoptosis induced by infusion may facilitate cardiomyocyte apoptosis in conditions of of angiotensin II is reduced by 50% in hearts of rats pressure overload of the heart. pre-treated with spironolactone, suggesting that the proThree types of findings suggest that, besides the mechapoptotic effect of the peptide could be due, at least in anic factor, local humoral factors may contribute critically part, to stimulation of aldosterone synthesis in vivo [110] . to cardiomyocyte apoptosis in arterial hypertension. First, increased apoptosis has been found not only in the 3 .2. Suppressors of apoptosis hypertrophied left ventricle but also in the right ventricle of SHR [80, 101, 102] , and the interventricular septum of It has been proposed that natural adaptation of carhypertensive patients [90] . Second, recent studies have diomyocytes to chronic injury (such as arterial hypertenshown that the ability of antihypertensive treatment to sion) is associated with upregulation of protective factors prevent apoptosis in SHR [80, 101, 102] and to reduce and / or downregulation of death factors (as mentioned apoptosis in hypertensive patients [90] is independent of its before) [111] . For instance, besides hypertrophic and antihypertensive efficacy. Third, apoptosis was not detectapoptotic pathways, biomechanical stress of the heart that able in the left ventricle of patients with valvular aortic occurs in conditions of pressure overload can also induce stenosis and increased left ventricular systolic pressure survival pathways in the cardiomyocyte [112] . There is [103] .
normally a balance between hypertrophic and survival Several arguments suggest that angiotensin II may be signals on one hand, and apoptotic signals on the other one of the humoral factors potentially involved in carhand, and cell death occurs in response to a persistent shift diomyocyte apoptosis in hypertension. First, carin this balance [113] . diomyocyte apoptosis increases in angiotensin II-infused
The transmembrane signal transducer gp130 molecule has been proposed to exert a survival effect in car-4 . Pathophysiological impact diomyocytes, mediating apoptosis-suppressor signals triggered by members of the interleukin-6 (IL-6) cytokine
From a pathophysiological point of view, hypertension family, including cardiotrophin-1 (CT-1) and leukemia affects the myocardium at two different stages [119] . In inhibitory factor (LIF) [114] . In support of this, it has been both humans and animal models, pressure overload is shown that left ventricular gp130 knockout mice develop a characterized by a period of compensation in which left rapid dilated cardiomyopathy with massive cardiomyocyte ventricular concentric hypertrophy normalizes systolic wall apoptosis in response to mechanical overload [115] . Interstress and contractile function is preserved. The period of estingly, an association of diminished expression of both adaptation, which may last for weeks in rodents and gp130 and LIF proteins with increased cardiomyocyte months to years in humans, is inexorably followed by a apoptosis has been found in the heart of SHR [116] . It can transition to cardiac failure. This transition is characterized thus be hypothesized that inhibition of the gp130 signaling by impaired survival, the onset of chamber dilatation with pathway in arterial hypertension decreases the survival the failure of further concentric hypertrophic growth to capability of cardiomyocytes and makes them more susnormalize load, and progressive contractile dysfunction. A ceptible to apoptotic factors. In accordance with this number of observations suggest that the transition to possibility are findings from our laboratory showing that, failure relates mainly to changes in the composition of the compared with cardiomyocytes isolated from normotensive motor unit and cytoskeleton of cardiomyocytes [120] , Wistar Kyoto (WKY) rats, cardiomyocytes isolated from alterations in the metabolism of the extracellular matrix SHR exhibit increased susceptibility to the apoptotic [121] and cardiomyocyte loss due to multiple mechanisms effects of angiotensin II [107] .
of death, including apoptosis [122] . Besides a reduction in Several data suggest that ischemia is the main perturbathe number of cardiomyocytes, apoptosis may contribute to tion challenging the equilibrium between cell survival and heart failure through different pathways [48, [123] [124] [125] ] apoptosis in the heart [117] . Specifically, diminished (Fig. 3) . energy availability may inhibit cell survival mechanisms and facilitate cell death. Coronary hemodynamic altera-4 .1. Compromising contractile function tions and structural and functional alterations of intramyocardial arteries are common in hypertensive heart As mentioned before, increased cardiomyocyte apopdisease [118] , thus ischemia may inhibit survival pathways tosis and diminished cardiomyocyte number have been and facilitate cardiomyocyte apoptosis in this condition.
found in the failing hearts of both SHR [82] and hyperten- sive patients [92] . Thus, apoptosis may be one of the ship and myofibrillar ATPase activity. In this regard, mechanisms involved in the loss of contractile mass and Laugwitz et al. [134] have demonstrated that caspase function in hypertensive cardiomyopathy. However, at activation is associated with cleavage of myofilaments, a present, there is no information concerning the magnitude disruption of sarcomeric structure and a reduction in the of cell loss required to depress cardiac contractility in the contractile force of failing myocytes, and that blockade of hypertrophied human heart when cell death occurs. Alcaspase activation improves contractility in the failing though most studies examining apoptosis in the end stage myocardium. Since, in cardiomyocytes, apoptosis may not heart report variable but low apoptosis rates (0.1-0.5% of be complete, allowing the cells to persist for a prolonged cardiomyocytes) [47, 60, 62, 63, 126, 127] , conservative asperiod within the myocardium, the detrimental effects of sumptions concerning the duration of apoptosis and the caspase activation on systolic function should not be constancy of the implied rate of cell death suggest that underestimated. This possibility is especially relevant apoptosis could result in the loss of up to 5-10% of the taking into account that overexpression of the active form myocardium per year [24] . Although the progressive of caspase-3 has been reported in the heart of hypertensive nature and poor survival in late-stage heart failure may patients [90] . well be consistent with such a substantial loss of carCytochrome c plays a major role in ATP production diomyocytes, it indicates that the heart should rapidly through mitochondrial oxidative phosphorylation. It has disappear. However, this contention does not consider that, thus been hypothesized that the release of cytochrome c as demonstrated recently in the human heart, carfrom mitochondria during the occurrence of the apoptotic diomyocytes may proliferate by mitotic division process should interfere with cardiomyocyte energy pro- [94, 128, 129] or regenerate from migrated undifferentiated duction and lead to functional impairment [48, 123] . The stem cells [130] . This does not imply that cell replication potential relevance of this mechanism is shown by the compensates for the extent of apoptotic loss in the diseased observation that both the ATP content and the capacity of myocardium, but allows the hypothesis that inadequate the mitochondria for oxygen consumption and oxidative cardiomyocyte division may be a critical event in the phosphorylation are significantly reduced in the failing evolution of the pathological heart to heart failure [131] .
heart compared to the normal heart despite the absence of Impaired myocardial contractile function may reflect not myocardial ischaemia [135, 136] . only a decrease in the number of viable, fully functional cardiomyocytes, but also a decrement in the function of 4 .2. Facilitation of cardiac remodeling viable cardiomyocytes, or a combination of these mechanisms [132] . It is well known that apoptosis is associated It has been suggested that alterations of the collagen with activation of caspases that mediate the cleavage of framework in the myocardium may play an important role vital and structural proteins. Communal et al. [133] [51] . First, in the progress of is required for the stimulation of the growth response of dying, a cardiomyocyte passes through phases of increased the noncardiomyocyte compartment of the myocardium. excitability or becomes automatic, at least until it is dead. The observation that fibrosis is associated with cell loss in Second, from a random grouping of several such dead the left ventricle of hypertensive patients [93] and patients cells, the process of normal activation in that area of heart with aortic stenosis [103] raises questions concerning the muscle must be deranged and redirected in a way that mechanism responsible for the modification of the interwould provide a suitable anatomical substrate for re-enstitium with accumulation of fibrillar collagen. As protrant arrhythmias. posed by Anversa et al. [140] , the death of individual
The potential clinical relevance of this mechanism is cardiomyocytes may be more common than generally shown by the observation that hypertensive carbelieved, and this phenomenon may stimulate discrete diomyopathy is associated with an increased incidence of healing processes contributing to expansion of the interboth ventricular arrhythmias and sudden cardiac death stitium. This proposal is further supported by the finding [152] . that failing hearts from SHR present the colocalization of collagen a type I gene expression to areas of focal 1 cardiomyocyte degeneration [141] , suggesting that car-5 . Further developments diomyocyte loss is associated with collagen type I production and focal scar formation in the SHR during the Because of the detrimental effects that cardiomyocyte transition from compensated hypertrophy to failure. apoptosis may exert in hypertensive cardiomyopathy, to Besides histologic remodeling of the myocardium, carrecognize and prevent or limit the magnitude of this diomyocyte apoptosis may also contribute to geometric phenomenon may be relevant in both assessing and remodeling of the left ventricular chamber. In fact, severe modifying the clinical outcome of patients with arterial cardiomyocyte apoptosis may lead to side-to-side slippage hypertension. Thus, methods for the measurement of of cells, mural thinning and chamber dilation [142] . Thus, cardiac apoptosis and strategies for the treatment of this wall restructuring secondary to severe cardiomyocyte lesion are currently being investigated and should be apoptosis may create an irreversible state of the myocarapplied to the study of the hypertensive heart. dium, conditioning progressive dilatation and the continuous deterioration of cardiac hemodynamics and ventricular 5 .1. Accurate in situ identification of apoptotic performance with time [143] [144] [145] [146] . cardiomyocytes
.3. Impairment of myocardial energy production
The most widely used technique for apoptosis quantification in tissue sections is the terminal deoxynucleotide Energy metabolism has been shown to be deranged in nick-end labeling (TUNEL staining or TdT labeling) the human hypertensive and failing myocardium [147, 148] . reaction based on the detection of DNA-39 ends. However, Although recent findings suggest that altered myocardial TUNEL staining is not specific for apoptosis. In fact, it has fatty acid metabolism may account for this abnormality in been shown that positive TUNEL staining is associated not hypertensive patients [148] , the possibility also exists that only with apoptotic cardiomyocytes but also with oncotic mitochondrial production of ATP is diminished in the (necrotic) cardiomyocytes or even viable cardiomyocytes hypertensive myocardium [149] . In this setting it is undergoing DNA repair [153, 154] . Therefore, because the interesting to consider that apoptosis is associated with loss rate of apoptosis is generally very low in normal hearts as of cytochrome c from the mitochondria and this may halt well as in diseased hearts, a high false-positive rate oxidative phosphorylation and the production of ATP, severely limits the interpretation of TUNEL-positive cells. namely in subsarcolemmal mitochondria [150] . NevertheThis problem was partially avoided by the development less, since apoptosis is an energy-requiring process, in of the Taq and Pfu labeling techniques that specifically conditions of severely diminished ATP availability the identify apoptotic DNA fragments [155, 156] . Using this mode of cell death would switch to necrosis. Then, one approach, Guerra et al. [60] have reported that carmight predict that apoptotic stimuli do not necessarily diomyocyte apoptosis occurs in end-stage cardiac failure at induce complete loss of cytochrome c from the mitorates 10-to five-fold lower than those previously reported chondria. Thus, the contribution of the mitochondrial using the TUNEL method. Nevertheless, as emphasized by pathway of apoptosis to the energy balance of the hySaraste and Pulkki [157] , the detection of DNA-39 ends pertensive myocardium remains to be clarified.
should always be accompanied by other confirmation protocols based on different apoptotic features such as process, by directly blunting the intracellular apoptotic caspase activation, assessment of caspase substrates (e.g., pathways or by inducing the survival pathways [96] . poly(ADP-ribose)polymerase), nuclear morphological
The in vivo effects of antihypertensive drugs on cardiac modifications, extracellular cell surface exposure of phosapoptosis in SHR have been reviewed elsewhere [125] phatidylserine or the internucleosomal pattern of DNA (Table 2) . Collectively, the available findings suggest that fragmentation.
the ability of antihypertensive drugs to inhibit cardiac apoptosis is independent of its antihypertensive efficacy 5 .2. Clinical recognition of cardiac apoptosis but can be related to their capacity to interfere with the pro-apoptotic actions of humoral factors. This is further Apoptosis activates mechanisms which cause the transsupported by clinical findings showing that, despite an location of phosphatidylserine from the internal to the identical antihypertensive efficacy, losartan but not amexternal leaflet of the plasma membrane [127, 158, 159] . lodipine reduced cardiomyocyte apoptosis in patients with Annexin-V is a phospholipid binding protein, which, in the hypertensive cardiomyopathy after 1 year of treatment 21 presence of Ca , specifically and reversibly interacts with [90] . the phosphoserine headgroup of phosphatidylserine in the As mentioned previously, oxidant stress is an important apoptotic cell [160] . This property has been the driving factor inducing cardiomyocyte apoptosis. Thus, antioxidant force for the research into annexin-V conjugated with a therapy, whether through administration of additional detectable marker such as biotin, a fluorochrome, or a antioxidants or by boosting innate antioxidant mechanisms, radioligand as a probe to measure apoptosis in vitro and in has been shown to be a viable approach in reducing vivo in animals and patients [161] . Technetium-99m-cardiac apoptosis in experimental conditions [169, 170] . In labeled annexin-V has been successfully used for the nonthe clinical setting, agents with antioxidant properties such invasive gamma imaging of cardiac apoptosis after acute as carvedilol or those that promote antioxidant activity, myocardial infarction, acute myocardial ischaemia, acute such as propranolol, are already used to treat patients with cardiac allograft rejection and malignant intracardiac hypertensive cardiomyopathy [171] . With the knowledge tumours [53, 162] .
that these antioxidants function in part by inhibition of Besides imaging studies, the determination of circulating apoptosis, the development of more potent therapeutic annexin-V may also be useful for the biochemical moniagents may be possible. On the other hand, recent data toring of the apoptotic process. In this respect, it has been suggest that activation of mitochondrial ATP-sensitive reported in humans that plasma levels of annexin-V determined by means of ELISA are increased eight-fold in T able 2 the early phase of acute myocardial infarction, and immeAvailable data on the effects of the systemic administration of antihypertensive drugs on cardiac apoptosis in spontaneously hypertensive diately decrease after the onset of pain [163] [166] . The current application of these protocols in patients though its use in cardiac diseases has been proposed [167] . potassium channels, either by the vasodilator diazoxide relevance to prevent the progression to heart failure in [172] or by the antianginal drug nocorandil [173] , inhibits patients with hypertensive cardiomyopathy. apoptosis induced by oxidative stress in cultured rat neonatal cardiomyocytes.
ACE inhibitors
Some experimental studies have focussed on the modi-A cknowledgements fication of apoptosis regulators and the blockade of apoptosis executors. For instance, overexpression of humanÁ rantxa Gonzalez is the recipient of a research training anti-apoptotic protein Bcl-2 decreases cardiac apoptosis grant (00 / 9296) from the Fondo de Investigaciones and improves cardiac function in transgenic mice after Sanitarias (FIS), Ministry of Health, Spain. ischemia / reperfusion [174] . Similar in vitro and in vivo effects have been reported with low molecular weight caspase inhibitors [175] . Interestingly, some of these R eferences compounds were effective not only in reducing cardiomyocyte apoptosis but also in improving cardiac func- 
. Conclusions
